Ditchcarbon
  • Contact
  1. Organizations
  2. Crucell Switzerland AG
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
CH
updated 14 days ago

Crucell Switzerland AG

Company website

Crucell Switzerland AG, a prominent player in the biopharmaceutical industry, is headquartered in CH and operates extensively across Europe and beyond. Founded in 2000, the company has made significant strides in vaccine development and biopharmaceutical production, focusing on innovative solutions for infectious diseases. Crucell is renowned for its unique technologies, including the PER.C6® cell line, which enhances the efficiency and safety of vaccine production. This proprietary platform has positioned Crucell as a leader in the market, contributing to notable achievements in public health initiatives. With a commitment to advancing healthcare, Crucell Switzerland AG continues to play a vital role in the global fight against infectious diseases, solidifying its reputation as a trusted name in the biopharmaceutical sector.

DitchCarbon Score

How does Crucell Switzerland AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

81

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Crucell Switzerland AG's score of 81 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.

88%

Let us know if this data was useful to you

Crucell Switzerland AG's reported carbon emissions

Inherited from Johnson & Johnson

Crucell Switzerland AG, headquartered in CH, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Johnson & Johnson, which means its climate commitments and initiatives are influenced by its parent organisation. Crucell Switzerland AG inherits its climate targets and performance metrics from Johnson & Johnson, which has established various sustainability initiatives. These include commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all at a cascade level of 2. However, specific reduction targets or achievements for Crucell Switzerland AG are not detailed in the available data. As part of its corporate family, Crucell is aligned with Johnson & Johnson's broader climate strategy, which aims to reduce greenhouse gas emissions across its operations. While no specific emissions data is available for Crucell Switzerland AG, the company's commitment to sustainability is evident through its association with these industry-standard initiatives.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

1990200620072008200920102011201220132014201520162017201820192020202120222023
Scope 1
308,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
751,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
00,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Crucell Switzerland AG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Crucell Switzerland AG is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Crucell Switzerland AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Adimmune Corporation

TW
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy